Septerna (SEPN) shares sank 59% amid heavy trading after the company said Tuesday it discontinued a phase 1 clinical trial of SEP-786 to treat hypoparathyroidism in healthy volunteers.
Intraday trading volume soared to nearly 6.27 million shares from a daily average of about 313,000.
Greenlane Holdings (GNLN) said Tuesday it struck deals to sell about $25.0 million of shares and investor warrants at $1.19 per unit to institutional investors.
Shares sank 37%, with intraday trading volume catapulting to over 2.92 million versus a daily average of about 122,000.
Medtronic (MDT) reported fiscal Q3 revenue below analyst projections as some distributors cut surgical inventory levels, weighing on the division's performance.
Shares slid 6.5% as intraday trading volume rose to over 8.32 million from the stock's daily average of about 6.7 million.
Price: 5.37, Change: -7.59, Percent Change: -58.56
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。